A recent study entitled “Electrocardiographic Findings in Systemic Lupus Erythematosus: Data From an International Inception Cohort” revealed that systemic lupus erythematosus (SLE) patients also suffer from cardiac anomalies. In the study, published in the journal Arthritis Care & Research, electrocardiographic methods were applied…
Applications for a series of grants from the National Research Program of the Lupus Foundation of America are currently open for investigators working on lupus-related research. The program is intended to fund critical areas of lupus scientific research, such as environmental triggers of the disease and health…
A new project is being launched by George Freeman MP, the British Parliamentary Under Secretary of State for Life Sciences in collaboration with several academic facilities and industry partners to improve treatment of systemic lupus erythematosus (SLE) in the UK. The MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified…
UBM Medica US, a company that delivers integrated and strategic communications solutions, recently announced that Rheumatology Network, an online network dedicated to rheumatologists, will feature a debate with experts on the barriers to investigation into new treatments for rheumatic diseases such as lupus. The topic is based on an article…
Despite ongoing efforts, there are still several gaps regarding lupus specificity in the Systemic Lupus International Collaborating Clinics (SLICC) network, according to a study that analyzed the recently reviewed criteria of the system. SLICC-12, the new set of criteria established in 2012 to classify systemic lupus erythematosus (SLE), was recently examined for the first…
Three lupus organizations are joining efforts to support the advancement of lupus research by granting the Lupus Insight Prize, a recognition of major, novel insights and/or discoveries with the potential to alter the thinking on lupus and high probability of creating further progress in the diagnosis and treatment of the condition. The prize will be granted…
ImmuPharma PLC and Simbec-Orion Group Limited recently announced a collaboration agreement for the execution of a Pivotal Phase III clinical study of ImmuPharma’s Lupuzor™, the company’s lead compound to treat Systemic Lupus Erythematosus, a chronic and life-threatening autoimmune disease. Lupuzor was granted Fast Track status by the Food and Drugs Administration (FDA); it…
A recent study conducted by a team of researchers from Taiwan found that patients with Systemic lupus erythematosus (SLE) who are treated with a specific dose of an antimalarial drug UCQ) are less prone to develop diabetes mellitus. However, those SLE patients that are threated with high-dose glucocorticoids are…
Researchers from St. Jude Children’s Research Hospital found that a protein involved in tumor formation suppression also plays a role in preventing autoimmune diseases and other problems through decelerating the immune response. The study was published in the Nature Immunology journal. The research team found that the tumor…
A team of researchers from Taiwan found that patients with systemic lupus erythematosus (SLE) have higher levels of T helper 17 cells than healthy controls, thus encouraging research in IL-17/IL-17R blockades as a potential treatment targets for SLE. The study entitled “Increased Th17 cells in flow…